Zweig Di Menna Associates LLC Roivant Sciences Ltd. Transaction History
Zweig Di Menna Associates LLC
- $1.25 Billion
- Q4 2024
A detailed history of Zweig Di Menna Associates LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Zweig Di Menna Associates LLC holds 99,500 shares of ROIV stock, worth $1.11 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
99,500Holding current value
$1.11 Million% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
316Shares Held
507MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$736 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$734 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$604 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$465 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$395 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.86B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...